Evidence-Based Medicine for Student Health Services
Robert J. Flaherty, MD
Swingle Student Health Service
Montana State University
Bozeman, MT 59717
 
Otitis Media 
  
Etiology Monitoring
Epidemiology Prognosis
Diagnosis Prevention
Treatment Patient Education
  
General Information
    
EBM for Student Health   
     Home Page   
    
About EBM   
   
EBM Resources  
  
Specific Conditions/Diseases 
 
   
     
 
   
Etiology  
The following environmental factors may increase potential risks of getting acute otitis media or otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection):  
    - Bottle-feeding rather than breast-feeding infants  
    - Passive smoking  
    - Group child-care facility attendance 
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
   
Epidemiology  
No evidence is cited.  
   
Diagnosis  
Clinical Diagnosis 
The symptom with the strongest association with acute otitis media was earache but sore throat, night restlessness and fever also had significant associations. Logistic regression analysis 
showed 71% of the cases to be correctly diagnosed on the basis of the symptoms of earache and night restlessness. The 
parents were able to predict the presence of acute otitis media with a sensitivity and specificity of 71 and 80%, respectively 
(positive predictive value, 51%; negative predictive value, 90%).  Pneumatic otoscopy is recommended for assessment of the middle ear because it combines visualization of the tympanic membrane (otoscopy) with a test of membrane mobility (pneumatic otoscopy). When pneumatic otoscopy is performed by an experienced examiner, the accuracy for diagnosis of otitis media with effusion  (fluid in the middle ear without signs or symptoms of ear infection) may be between 70 and 79 percent.  Half of ears with abnormal tympanograms may have otitis media with effusion. Because the strengths of tympanometry (it provides a quantitative measure of tympanic membrane mobility) and pneumatic otoscopy (many abnormalities of the eardrum and ear canal that can skew the results of tympanometry are visualized) offset the weaknesses of each, using the two tests together improves the accuracy of diagnosis.  
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
Laboratory/X-ray Diagnosis 
No evidence is cited.  
    
Treatment   
Antibiotics 
Antibiotics provide no reduction in pain at 24 hours, but a small reduction in pain at 2-7 days. There was no effect of antibiotics on complication rates, as measured by subsequent tympanometry or recurrence.  Early treatment of AOM with antibiotics can reduce the severity of pain, but the majority of children will feel better in 24 hours with or without antibiotics. Due to the poor quality of the available evidence, additional benefits or harm of treatment remain uncertain. Withholding antibiotic treatment while following closely with adequate analgesia is acceptable for children aged 2 years or older without a high fever or severe pain.  No statistically significant difference was found between antibiotic-treated children and controls under two years of age with acute otitis media, judged on the basis of clinical improvement within seven days.  Antimicrobial drugs have a modest but significant impact on the primary control of acute otitis media (AOM). Six of every seven children with AOM either do not need antibiotics for primary control or will not respond to antibiotic therapy. All seven children have to be treated  because we cannot predict which one of the seven is both at risk for failure and responsive to antibiotics. Treatment with extended spectrum antibiotics does not increase resolution of acute symptoms or middle ear effusion when compared to penicillin and ampicillin/amoxicillin. Initial therapy should be guided by considerations of safety, tolerability, and affordability, and not by the theoretical advantage of an extended antibacterial spectrum.  Trials of short-acting antibiotics (penicillin V potassium, amoxicillin [-clavulanate], cefaclor, cefixime, cefuroxime, cefpodoxime proxetil, cefprozil) were compared to trials of intramuscular ceftriaxone and oral azithromycin. 5 days of short-acting antibiotic use is effective treatment for uncomplicated acute otitis media in children.  Cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten were compared to conventional antibiotic therapies (usually amoxicillin/clavulanate, cefaclor or cephalexin) for community acquired infections. Infections included acute otitis media, pharyngitis, sinusitis, bronchitis, pneumonia, urinary tract infection and skin and skin-structure infections. The newer agents appear to be as clinically effective as conventional therapies (but not more effective) for the treatment of common community-acquired infections. They may also have the potential to improve compliance due to their once/twice daily mode of 
administration.  
  • Caveats
    • Age group studied: Unknown
    • Type/sample size: Analytical review of studies: acute otitis media: 19 studies, pharyngitis: 13 studies, sinusitis: 4 studies, bronchitis: 10 studies, pneumonia: 7 studies, urinary tract infection: 11 studies, skin and skin-structure infections: 4 studies. Most studies consisted of 30-50 patients in each arm
    • Population: Unknown
    • Outcome measure: Clinical response to therapy
    • For some of these infections other studies show that there is no evidence that any antibiotic therapy is beneficial
  • Citations
Observation OR antibiotic therapy are treatment options for children with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection) that has been present less than 4 to 6 months and at any time in children without a 20-decibel hearing threshold level or worse in the better-hearing ear. For the child who has had bilateral effusion for a total of 3 months and who has a bilateral hearing deficiency (defined as a 20-decibel hearing threshold level or worse in the better-hearing ear), bilateral myringotomy with tube insertion becomes an additional treatment option. Placement of tympanostomy tubes is recommended after a total of 4 to 6 months of bilateral effusion with a bilateral hearing deficit.  
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
Receiving a prescription for an antibiotic for a URI was not associated with increased patient satisfaction. Better to spend time explaining the nature of a particular illness and the physician's choice of treatment.    
Other Treatments    
A number of treatments are not recommended for treatment of otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection) in the otherwise healthy child age 1 through 3 years.  
    - Steroid medications 
    - Antihistamines and/or decongestants 
    -  Adenoidectomy in the absence of adenoid pathology 
    - Allergy management 
    - Chiropractic, holistic, naturopathic, homeopathic, 
         traditional/indigenous, or other treatments
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
     
Monitoring 
Although hearing evaluation may be difficult to perform in young children, evaluation is recommended after otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection) has been present bilaterally for 3 months, because of the strong belief that surgery is not indicated unless otitis media with effusion is causing hearing impairment (defined as equal to or worse than 20 decibels hearing threshold level the better hearing ear).  
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
  
Prognosis   
There is no rigorous, methodologically sound research to support the theory that untreated otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection) results in speech or language delays or deficits.   
  • Caveats
    • Age group targeted: 1 through 3 years
    • Type/sample size: Meta-analysis (158 studies)
    • Population characteristics: Patients with otitis media with effusion (fluid in the middle ear without signs or symptoms of ear infection), otherwise healthy with  no craniofacial or neurologic abnormalities or sensory deficits 
    • Outcome measures: Discomfort and behavior changes, effect of hearing loss on speech and language development
  • Citations
   
Prevention  
No evidence is cited.   
  
Patient Education 
The following patient education materials are consistent with the available evidence. 
Rev. 8/28/99
 
This Web site developed and maintained by Robert J. Flaherty, MD. 
Comments, additions and corrections are encouraged.